VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SGRY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SGRYSurgery Partners, Inc.
$15.82$2.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSGRYQuarterly Cash Flow

Surgery Partners, Inc. (SGRY) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Surgery Partners, Inc. (SGRY) quarterly cash flow statement — complete operating, investing & financing history

SGRY Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Cash from Operations11.7M103.4M83.6M81.3M6M111.4M65.2M82.8M40.7M62.6M104.6M52.1M
Operating CF Margin %1.44%11.68%10.18%9.84%0.77%12.89%8.46%10.86%5.67%8.51%15.52%7.8%
Operating CF Growth %95%-7.18%28.22%-1.81%-85.26%77.96%-37.67%58.93%-45.37%769.44%252.19%23.75%
Net Income-35.9M025.3M0-300K-46.6M6.4M-15.5M24.3M-1M-4.9M57.7M
Depreciation & Amortization38.5M039.5M036.3M33.9M50.2M34.8M33.7M31.1M28.9M24.4M
Stock-Based Compensation5.8M02.6M07.6M6.2M7.1M04.9M4.5M04.6M
Deferred Taxes005.1M0-300K121.2M2.7M5.1M2.5M9.1M700K-9.7M
Other Non-Cash Items3.3M121.8M29.5M98M19.6M28.2M27M79.9M13M84.6M58.1M4.9M
Working Capital Changes0-18.4M-18.4M-16.7M-56.9M-31.5M-28.2M-21.5M-37.7M-65.7M21.8M-29.8M
Change in Receivables0-46.1M-16.2M3.7M4.8M-40.9M-19.1M-17.5M5.4M-29M-13.1M-13.9M
Change in Inventory000000000000
Change in Payables000000000000
Cash from Investing-13.4M-126.1M-46.2M2.1M-76.4M-111.7M-49.6M-244.1M-83.1M-58.1M-25.6M-71.2M
Capital Expenditures-16M-12.8M-19.8M-23.4M-22.7M-22.3M-20.2M-26.9M-21M-19.8M-18.9M-25.8M
CapEx % of Revenue1.97%1.45%2.41%2.83%2.93%2.58%2.62%3.53%2.93%2.69%2.8%3.86%
Acquisitions-4.2M-109.5M-800K-4M-44M-87M-24.9M-210M-56.6M-31.2M-5.6M-41.6M
Investments------------
Other Investing6.8M-3.9M-25.6M29.5M-5.9M-2.4M-4.5M-11.5M-5.5M-7.4M-300K-3.8M
Cash from Financing-55.9M59.2M-84.1M-62.6M30.2M48M-7.3M189.6M31.7M-44.6M-20.4M-49M
Debt Issued (Net)0110.6M-33.1M-11.5M94.3M95.4M33.4M234.4M72.3M7.2M17.2M-5M
Equity Issued (Net)000000000000
Dividends Paid000000000000
Share Repurchases000000000000
Other Financing-55.9M-51.4M-51M-51.1M-64.1M-47.4M-40.7M-44.8M-40.6M-51.8M-37.6M-44M
Net Change in Cash-57.6M36.5M-46.7M20.8M-40.2M47.7M8.3M28.3M-10.7M-40.1M58.6M-68.1M
Free Cash Flow-4.3M90.6M63.8M57.9M-16.7M89.1M45M55.9M19.7M42.8M85.7M26.3M
FCF Margin %-0.53%10.24%7.77%7.01%-2.15%10.31%5.84%7.33%2.75%5.82%12.71%3.94%
FCF Growth %74.25%1.68%41.78%3.58%-184.77%108.18%-47.49%112.55%-60.76%376.13%591.13%33.5%
FCF per Share-0.030.710.500.46-0.130.710.360.440.160.340.680.21
FCF Conversion (FCF/Net Income)-0.33x-6.89x-3.68x-32.52x-0.16x-1.03x-2.06x-5.34x-3.28x-62.60x-21.35x2.76x
Interest Paid000000000000
Taxes Paid000000000000